To our knowledge, no HAP strategy has yet been described for chondrosarcoma which is characterized by overexpression of hypoxia marker HIF-1α that may play an important role in the prognosis of this tumor [40]. The gene discussed is HIF1A; the disease is chondrosarcoma.